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Background: Given the polymicrobial nature of pulmonary infections in patients
with cystic ﬁbrosis (CF), it is essential to enhance our knowledge on the composition
of the microbial community to improve CF management. In this study, we developed
a pyrosequencing approach to extensively explore the diversity and dynamics of
fungal and prokaryotic populations in CF lower airways.
Methodology and Principal ﬁndings: Fungi and bacteria diversity in eight
sputum samples isolated from CF patients was investigated using complementary
conventional microbiological culturing and high-throughput pyrosequencing.
The unveiled microbial community structure was compared to the clinical proﬁle
of the CF patients. Pyrosequencing conﬁrmed recently reported bacterial diversity
and observed complex fungal communities, in which more than 60% of the species
or genera had not been identiﬁed in cultures. Strikingly, the diversity and species
richness of fungal and bacterial communities was signiﬁcantly lower in patients with
decreased lung function and poor clinical status. Phylogenetic analysis showed high
molecular diversity at the sub-species level for the main fungal and bacterial taxa
identiﬁed in the present study. Anaerobes were rarely isolated with Pseudomonas
aeruginosa, which was more likely to be observed in association with Candida
albicans.
Conclusions: In light of the new concept of microbiota, we viewed the microbial
community as a unique pathogenic entity. We thus interpreted our results to highlight
the potential interactions between microorganisms and the role of fungi in the
context of improving survival in CF.
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Introduction: Molecular based studies have recently challenged the view that the
healthy lung is sterile and have shown that the lung may harbour its own unique
microbiota. The aim of this study was to determine, using culture based methods,
the composition of the airway microbiota in healthy controls age-matched to patients
with both CF and non-CF related bronchiectasis (BE).
Methods: Induced sputum samples or cough swabs were collected from healthy
volunteers and processed using strict anaerobic bacteriological techniques. Bacteria
within the samples were detected by plating on selective agars, quantiﬁed by total
viable count and identiﬁed by PCR and sequencing of 16S ribosomal RNA genes.
Results: Samples were collected from 29 healthy volunteers (n = 20 [9M:11F],
age-matched to CF; n = 9 [6M:3F], age matched to BE) The mean (SD) age for
volunteers in the age-matched CF and BE groups were 58.2 (4.7) and 30.4 (8.0)
years, respectively. No bacteria were detected in samples from 2 CF controls with
anaerobes not detected in a further 3 samples. Bacteria were detected in samples
from all BE controls. Aerobes from a range of genera including Streptococcus,
Rothia and Staphylococcus were detected in numbers ranging from 105 to 107cfu/g
of sputum. Anaerobes from genera including Prevotella, Veillonella, and Actino-
myces were also detected but in lower numbers ranging from 103 to 106 fu/g of
sputum.
Conclusion: Aerobes and anaerobes have been detected by culture in the lungs of
healthy people. Although the genera detected are similar to those we have previously
detected in the lungs of patients with CF and BE, they are less frequently detected
and present in much lower numbers.
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Objectives: Our objective was to assess the cohort of patients attending our
paediatric cystic ﬁbrosis (CF) clinic for colonisation with 6 clinically signiﬁcant
pathogens and to determine if lung function differed between these groups.
Methods: We reviewed the results of all sputum samples over the previous
12 months on the cohort of paediatric CF patients attending our centre. We recorded
colonisation with any of the following: Staphylococcus aureus (SA), methicillin-
resistant Staphylococcus aureus (MRSA), Stenotrophomonas maltophilia (SM),
Acinetobacter species, Pseudomonas aeruginosa (PA) [mucoid, non-mucoid or
multi-drug resistant (MDRP)] and Burkolderia cepacia complex (BCC). We then
correlated sputum results with mean forced expiratory volume in the ﬁrst second
percent predicted (FEV1).
Conclusions: Seventy of 90 paediatric patients attending our CF clinic were old
enough to have reliable measurements of FEV1. Correlation of sputum culture
reports with FEV1 was as follows: 38/70 (54.3%) colonised with SA with mean
FEV1 of 85%, 7/70 (10%) colonised with MRSA with mean FEV1 of 67%, 23/70
(32.9%) colonised with PA with mean FEV1 of 75%, 6/70 (8.6%) colonised with
SM with mean FEV1 of 81%, 3/70 (4.3%) colonised with Acinetobacter species
with mean FEV1 of 87%, and 1/70 (1.4%) colonised with BCC with mean FEV1
of 76%.
Analysis of PA data revealed 13/23 (57%) colonised with non-mucoid PA (mean
FEV1 86%), 10/23 (43%) colonised with mucoid ± non-mucoid PA (mean FEV1
70%) and no patient colonised with MDRP. In conclusion, CF patients with mucoid
PA and MRSA constitute a small proportion of our total clinic cohort but have lower
lung function and must be closely monitored.
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To diagnose airway infection non-invasively is an important component of clinical
care of CF patients. Sputum samples are used in older patients with more advanced
disease with reliable results. Diagnostic problems may be signiﬁcant in non-sputum
producing patients.
We have compared 20 throat swabs and pharyngeal suction specimens taken
contemporaneously in 18 CF patients (11M and 7F, mean age 9aa9m, range 2aa7m–
27aa).
In 10 cases pharyngeal suction specimens culture was positive for bacteria species
not identiﬁed in the throat swabs (4 Pseudomonas aeruginosa, 4 Staphylococcus
aureus and 2 Haemophilus inﬂuenzae). In three cases the positivity for P. aeruginosa
corresponded with the ﬁrst isolation and had led to an eradication therapy. In two
cases throat swabs were positive, for P. aeruginosa and S. aureus respectively, as
pharyngeal suction specimens were negative. Pharyngeal suction, a procedure very
low-time consuming and inexpensive, was well tolerated in all our patients.
Our results show that in non-sputum producing CF patients may be useful to
associate pharyngeal suction to throat swabs for the diagnosis of lung infections.
This more sensitive diagnostic strategy could above all anticipate the detection of
ﬁrst PA infection with great beneﬁts.
